Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Barinthus Biotherapeutics' Depreciation & Amortization (CF) was $820,000 in Q2 2026, down 59.0% from $2 million a year earlier and down 4.2% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Barinthus Biotherapeutics' Depreciation & Amortization (CF) was $3.49 million through Jun 30, 2026, down 49.8% year-over-year; for FY2025, it was $5.85 million, up 0.8% from FY2024.

  • Depreciation & Amortization (CF) has now increased for five consecutive years, with a five-year compound annual growth rate of 94.9% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $5.8 million in FY2024 (+6.8%), $5.43 million in FY2023 (+25.6%), $4.32 million in FY2022 (+618.1%) and $602,000 in FY2021 (+189.4%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q4 2021.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for four straight quarters, with an average decline of 14.2% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2022 (growth of 950.0%); the worst was Q2 2026 (a decline of 59.0%).
  • Per Business Quant data, BRNS's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $856,000 (Q1 2026), $909,000 (Q4 2025) and $901,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn - 820,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 820,000.00
Mar 31, 2026 856,000.00
Dec 31, 2025 909,000.00
Sep 30, 2025 901,000.00
Jun 30, 2025 2.00 Mn
Mar 31, 2025 2.03 Mn
Dec 31, 2024 1.43 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.44 Mn
Sep 30, 2023 1.47 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 1.22 Mn
Dec 31, 2022 1.18 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 992,000.00
Mar 31, 2022 966,000.00
Dec 31, 2021 321,000.00
Sep 30, 2021 85,000.00
API Access

Barinthus Biotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BRNS&period=max&api_key=YOUR_API_KEY